Touching cancer cells with a Nanoscale Finger
Cellens is pioneering a novel diagnostic modality based on single cell biophysical markers. By touching cells at the nanoscale level, we uncover unique physical fingerprints of cancer cells that are ideal for accurate and non-invasive cancer detection.
WHAT WE ARE DOING
Mechanobiology + AI/ML =
New Class of Diagnostic Modality
Cancer cells feel different to the touch. By extracting and revealing new biophysical insights of cancer cells, Cellens can detect subtle physical differences as cells go through malignant transformation.
Our preliminary clinical data shows an overall 94% accuracy (91% sensitivity, 82% specificity) in detecting recurrence of bladder cancer using voided urine of patients with bladder cancer. This opens a new era in non-invasive cancer diagnostics as we tap into the power of biophysical markers.
Maybe delete this section
A NONINVASIVE, URINE-BASED CANCER DIAGNOSTICS PLATFORM
Octosense Platform
Cellens platform is scalable and applicable to different types of cancer cells, extracted from bodily fluid to detect various clinical conditions. Our peer-reviewed, preliminary data highlights the superior performance of our platform to achieve high accuracy in detecting bladder cancer.
Proprietary Cell Fixation
Our preservation method ensures high urine sample stability over time and during transport.
Urine Sample Processing
We collect cells by extracting them from voided urine samples.
Cell Surface Scanning
Our nanoscale cell surface scanning device produces detailed, accurate multi-parametric data on cell biophysical properties.
Machine Learning Analysis
Our proprietary machine learning algorithm analyzes key biophysical markers from scanning results and detects cancer in patient sample.
Research & Development
Collaborating with leading academic medical centers and cancer institutes on our clinical studies
